2.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
Published on: 2025-10-18 00:37:15 - Trung tâm Dự báo KTTV quốc gia
What technical models suggest about SELLAS Life Sciences Group Inc.’s comeback2025 Earnings Impact & High Accuracy Investment Signals - newser.com
Smart tools for monitoring SELLAS Life Sciences Group Inc.’s price actionJuly 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com
How institutional ownership impacts SELLAS Life Sciences Group Inc. stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
How SELLAS Life Sciences Group Inc. stock valuations compare to rivalsPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can SELLAS Life Sciences Group Inc. stock sustain revenue growth2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Published on: 2025-10-15 04:42:51 - newser.com
How to recover losses in SELLAS Life Sciences Group Inc. stockMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Quantitative breakdown of SELLAS Life Sciences Group Inc. recent move2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
How to build a custom watchlist for SELLAS Life Sciences Group Inc.2025 Support & Resistance & Weekly Momentum Picks - newser.com
SELLAS Life Sciences to Present In Vivo Preclinical Data - GlobeNewswire
SELLAS to present CDK9 inhibitor data for T-cell leukemia at ESMO - Investing.com India
Biotech Stocks Surge After Hours On Trial Updates, Data Momentum - Nasdaq
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment - Stocktwits
What analyst consensus says on SELLAS Life Sciences Group Inc. stockChart Signals & Risk Managed Investment Signals - newser.com
Using R and stats models for SELLAS Life Sciences Group Inc. forecastingTrade Signal Summary & Capital Efficient Trading Techniques - newser.com
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025 - GlobeNewswire
SELLAS Life Sciences Group, Inc. to Present in Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia AAt the European Society for Medical Oncology Congress 2025 - MarketScreener
What data driven models say about SELLAS Life Sciences Group Inc.’s futureMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Using data models to predict SELLAS Life Sciences Group Inc. stock movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - newser.com
How to integrate SELLAS Life Sciences Group Inc. into portfolio analysis toolsPortfolio Performance Report & High Return Trade Guides - newser.com
Published on: 2025-10-09 03:27:21 - newser.com
Published on: 2025-10-09 03:07:14 - newser.com
Is SELLAS Life Sciences Group (NASDAQ:SLS) In A Good Position To Invest In Growth? - Sahm
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Significant Decrease in Short Interest - Defense World
Multi factor analysis applied to SELLAS Life Sciences Group Inc.July 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Using Python tools to backtest SELLAS Life Sciences Group Inc. strategies2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Can SELLAS Life Sciences Group Inc. (RXK3) stock double in coming years2025 Short Interest & Stock Market Timing Techniques - newser.com
Published on: 2025-10-06 05:59:31 - newser.com
SELLAS Extends Times Square Sublease Agreement - TipRanks
Why SELLAS Life Sciences Group Inc. (RXK3) stock benefits from AI revolutionEarnings Risk Summary & Community Consensus Picks - newser.com
Published on: 2025-10-03 03:10:59 - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):